Bernhard Scheiner - Concepedia

Author

Bernhard Scheiner

Medical University of Vienna ORCID

Also Known As

B Scheiner, B. Scheiner, B., Scheiner, Bernhard Scheiner, David James Pinato, Jean-Charles Nault, Scheiner, B.

385

Publications

7.4K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Imperial College London Johannes Gutenberg University Mainz Medizinische Hochschule Hannover University Medical Center of the Johannes Gutenberg University Mainz

About

Bernhard Scheiner is an author at Medical University of Vienna specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	591
2	Health Sciences	3	3	87
3	Public Health	1	1	15
4	Epidemiology	1	1	15
5	Gastroenterology	1	1	42

Bernhard Scheiner

121

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
NASH limits anti-tumour surveillance in immunotherapy-treated HCC Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, Nature	2021	1.2K
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Journal of Hepatology	2021	284
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease Mònica Pons, Salvador Augustín, Bernhard Scheiner, The American Journal of Gastroenterology	2020	223
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Hepatology	2022	218
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality Dalila Costa, Benedikt Simbrunner, Mathias Jachs, Journal of Hepatology	2020	186
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome Salvatore Piano, Hartmut Schmidt, Xavier Ariza, Clinical Gastroenterology and Hepatology HepatologyLiver PhysiologyPathologyAssociation Between GradeHepatology Inflammation	2018	168
Programmed cell death protein‐1 (<scp>PD</scp>‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort Bernhard Scheiner, Martha M. Kirstein, Florian Hucke, Alimentary Pharmacology & Therapeutics	2019	130
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease Georg Semmler, Elias Laurin Meyer, K Kozbial, Journal of Hepatology	2021	126
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis Benedikt Hofer, Benedikt Simbrunner, Lukas Hartl, Clinical Gastroenterology and Hepatology	2022	108
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study Claudia Angela Maria Fulgenzi, Jaekyung Cheon, Antonio D’Alessio, European Journal of Cancer Drug SafetyOncologyMedicineClinical TrialsTherapeutic Efficacy	2022	98

Page 1